Post on 25-Mar-2020
transcript
1
Challenges of Fragility Fracture Challenges of Fragility Fracture TreatmentTreatment
David MarshInstitute of OrthopaedicsUniversity College of LondonRoyal National Orthopaedic HospitalStanmoreEngland
2
Keep the patient alive
Fix the fracture
Keep patient mobile
Keep patient from returningto your fracture unit
Quality control of process
Acute medical management
Surgical challenges
Multidisciplinary rehab
Osteoporosis managementand secondary prevention
Optimal care of fragility fracture patient:Goals, challenges and solutions
3
Keep the patient alive Acute medical management
Optimal care of fragility fracture patient:Goals, challenges and solutions
4
Complexity of elderly patients• Mean age hip fracture = 80 yrs
• Comorbidities (median ASA 3) – Murmurs
– Renal - Dialysis
– COPD - home O2
– Diabetes
– Delirium / dementia
– Pseudo-obstruction
– Alcohol abuse
• Impaired metabolic response to injury– Hyponatraemia
• Management problems– Consent
– Theatre scheduling
– Discharge planning
• Polypharmacy– Warfarin
– Plavix
– Neurotropics
5
Acute medical management
• Slow but steady rise in age of patients presenting with fragility fractures. Many have multiple co-morbidities
• Difficult judgement – balance between medical optimisation and prompt surgery
• Inexperienced surgical trainees not the best people to look after such people and prepare them for surgery
• Ideal solution is close supervision by senior physicians having expertise with elderly patients– pre- and peri-operatively, not just for rehabilitation
6
Senior medical backup desired
• Can come from different specialists, depending on health care system – Anaesthesia - Geriatrics
– Cardiology - Respiratory medicine
– Internal medicine
• Orthogeriatrics may play larger role in future
7
Quality service is cheaper in the endQuality service is cheaper in the end
The pay-off from orthogeriatric care in the acute phase
• Superior medical care
• Optimal scheduling of fracture surgery
• Better communication with patients and relatives
• A leader for the multidisciplinary team
8
Alternative models for orthogeriatric care
• Orthopaedic doctors and nurses supported by visiting medical specialist
• Nurse specialists on fracture wards, supervised by geriatricians
• Geriatricians employed on fracture wards
• Elderly fracture patients admitted to geriatric wards
9
Keep the patient alive
Fix the fracture
Acute medical management
Surgical challenges
Optimal care of fragility fracture patient:Goals, challenges and solutions
10
Altogether, these factors lead to a higher risk of failure at the implant-bone interface before healing achieved
Main surgical challenges
• Impaired ability of osteoporotic bone to hold screws
• Crushing of cancellous bone with creation of voids after fracture reduction
11
Some surgical solutions
• Avoid the problem with arthroplasty– Allow early mobilisation
• Improve implants for osteoporotic bone– Fixed angle locking plates
– Hydroxyapatite coating of screws
• Use IM nail instead of onlay devices for diaphyseal fractures
• Fill voids with cement
12
Proven arthroplasties relevant to challenging osteoporotic fractures
Hip Shoulder Knee Elbow
Images courtesy of John Keating
13
Arthroplasty as an alternative to fixation: Hip
• Hemiarthroplasty established and widely preferred to ORIF in displaced subcapital fractures– But still controversial
• Total arthroplasty increasing– Keating et al. J Bone Joint Surg 2006. 88A:249-60:
THR greater initial cost but cheaper in the long run with better function.
14
Arthroplasty as an alternative to fixation: Knee
• Technically demanding• Revision components often needed • Complications common
15
Arthroplasty as an alternative to fixation: Shoulder
• Useful particularly for 3-part and 4-part fractures and fracture dislocations
• Early treatment best
• Good pain relief, but poor movement and function
• Soft tissues influence outcome
16
Arthroplasty as an alternative to fixation: Elbow
• C3 distal humerus, below condyles, radial head
• Good results in small, uncontrolled series
• Probably better than ORIF
• More studies needed
17
F. 82yrs
1 YEAR1 MONTHPOST OP
Locking plates
• Screw head threaded –engages with hole in plate
• Single mechanical unit –internal fixator
• No compressive force on periosteum
18
Plecko and Kraus, Oper Orthop Traumatol 2005; 17:25-50
Fixed angle plate for shoulder
• Pullout from head less likely with diverging, fixed-angle screws
• Increases scope for ORIF as opposed to hemiarthroplasty
19
Fixation augmentation with hydroxyapatite-coated screws
OsteoTite HA-coated external fixation pin
HA-coated AO/ASIF lag screw
HA-coated AO/ASIF cortical bone screw
HA-coated AO/ASIF cancellous bone screw
Magyar G et al, J Bone Joint Surg Br. 1997;79:487-9Moroni A et al, Clin. Orthop. 1998;346:171-77Moroni A et al, Clin Orthop. 2001;388:209-17Moroni A et al, J. Bone Joint Surg. Am. 2001;83-A(5):717-21Sandèn B al, J. Bone Joint Surg. Br. 2002;84(3):387-91Caja VL et al, J. Bone Joint Surg. Am. 2003;85-A(8):1527-31Moroni A et al, Clin. Orthop. 2004 ;425:87-92 Moroni A et al, J. Bone Joint Surg. Am. 2005 ;83-A(5):717-21
20
HA-COATED SCREWSTANDARD SCREW
A. Moroni et al. J. Orthop. Trauma 2002; 16:257-63
Improved osseointegration with HA-coated screws
21
Moroni et al. Clin Orthop Relat Res. 2004; 425:87-92
HA-coated dynamic hip screw
Study Aim:
To compare DHS fixed with standard vs HA-coated AO/ASIF screws in osteoporotic patients with trochanteric fractures
Standard HA-coated
22
StandardScrews
HA-coatedScrews
ns
Study population
No. of patients 60 60
Age (yrs) 81 ± 8 81 ± 6
BMD 538 ± 105 568 ± 111
AO A1 42% 48%
AO A2 58% 52%
Moroni et al. Clin Orthop Relat Res. 2004; 425:87-92
23
126
128
130
132
134
136
POST-OP 6 MONTHS
Standard ScrewsHA-Coated Screws
p=0.008
Ang
le (d
egre
es)
Moroni et al. Clin Orthop Relat Res. 2004; 425:87-92
Standard vs HA-coated screws:Femoral neck-shaft angle
24
Harris Hip Score
0
20
40
60
80
100
Standard HA-Coated
p=0.0070
1
2
3
4
5
Standard HA-Coated
p<0.05
Lag Screw Cut-out
Moroni et al. Clin Orthop Relat Res. 2004; 425:87-92
Standard vs HA-coated screws
25
POST-OP
2 MONTHS
6 MONTHS
F 83yrs
Standard Screw: Complications
26
6 WEEKS 6 MONTHS
F 82 yrs
Possible solution: HA-coated screw
Note bone growth around the tip of the screws beyond the exit cortex
27
HA-coated screws: Wrist external fixator
Caveat: HA-Coated Pins can be difficult to remove from cortical bone
28
Void filling with bone substitutes
• Deformation and loss of support by crushing of cancellous bone. Relevant in metaphyseal long-bone fractures and spine
• Inert materials, such as PMMA cement, vs. potentially integrating scaffold, i.e. graft
• Autologous bone graft limited. Allograft carries risk of disease transmission. Artificial substitute desirable
• Matrix (scaffold) plus or minus inductive molecules or cells
29
Void filling with bone substitutes
30
Calcium phosphate cement augmentation
31
Void Filling / Support of trabecular bone in metaphyseal fractures
Maintains radial length, avoids re-operation and increases grip strength.
Constantz et al. Science 1995; 267:1796-99
32
Vertebral fragility fracture impairs quality of life more than we think
Kanis et al.Osteoporos Int 2001; 12:417-427
Loss of utilities, over 1 year
calculated from EQ5D
-0.35
0
-0.3
-0.25-0.2
-0.15-0.1-0.05
Vertebral Hip Shoulder Wrist
• Predicted prevalence of vertebral fractures in the E.U. – 2000 : 23.7 million
– 2050 : 37.3 million
33
Vertebroplasty and kyphoplasty
• Filling void in crushed vertebral body with PMMA
• Patient prone – transpedicular injection of cement
• Vertebroplasty – high pressure injection – good pain relief
• Kyphoplasty – pre-insertion of balloon to create a void for low pressure injection – aiming for height restoration
34
Balloon kyphoplasty : Can you uncrush a bone?
35
Kyphoplasty
36
Efficacy of vertebroplasty and kyphoplasty
• Similar efficacy in pain relief, better than conservative treatment
• Kyphoplasty fewer adverse events (leakage, VTE)– Stronger evidence for functional and QOL Improvement
• Most experience to date with late, failed conservative cases– Sagittal correction with kyphoplasty may be better
if performed earlier
Taylor et al. Spine. 2006; 31:2747-2755
37
Osteoporosis therapy and fracture healing
Theoretical concern:
Reduction of bone turnover by anti-resorptive drugs may inhibit fracture healing
38
Anti-resorptive drugs and fracture healing
• Large clinical trials of anti-resorptive agents– 2000 - 7000 patients over 3 years
– no adverse events related to fracture healing
• Animal studies of fracture healing – delay in remodelling of callus
– no positive effect on restoration of mechanical strength
• Bisphosphonate may delay loosening of implants
• No clinical trials in humans directly testing effect of anti-resorptive therapy on fracture healing
39
Raloxifene, estrogen and alendronate affect the processes of fracture repair differently in
ovariectomized rats
• OVX vs sham-op in 3-month-old rats– Closed, nailed femoral shaft fracture
– OVX alone, or with E, raloxifene (RAL), or alendronate (ALN)
• X-ray, QCT, biomechanical testing, histology– At 6 and 16 weeks
Cao et al. J Bone Miner Res 2002; 17:2237-46
40
Fracture healing properties vs sham control
6 weeks 16 weeksCallus size
Ultimate load
BMC
+
--
Callus size
Ultimate load
BMCLamellar/woven
Ovx alone +Ovx + E
Ovx + RALOvx + ALN + + + + -
• Alendronate delayed callus remodelling (lower ratio of lamellar to woven bone), but larger callus was stronger
• Alendronate delayed callus remodelling (lower ratio of lamellar to woven bone), but larger callus was stronger
Cao et al. J Bone Miner Res 2002; 17:2237-46
41
Balance of risks
Theoretical worries about importance of remodelling in fracture repair
Definite increase in fracture incidence if secondary prevention not initiated
But caution before treating with rigid internal fixation, requiring osteoclast-led remodelling
42
Anabolic therapy would remove this worry -preclinical evidence with PTH
• Paradoxical effect of PTH when given intermittently – anabolic for bone. Confirmed in clinical trials of osteoporosis treatment.
• Several groups show enhanced fracture healing in animal models– Andreassen 1999, 2001, 2004.
Komatsubara 2005. Alkhiary 2005
Alkhiary et al J Bone Joint Surg Am. 2005; 87A:731-41
43
Moroni et al. J Bone Joint Surg Am. 2005; 87 Suppl 2:42-51
Systemic bisphosphonate therapy may enhance HA-coated screw fixation
• Prospective randomised study in externally-fixed intertrochanteric fractures– Women aged 65+ with low BMD and no prior BP therapy
– Intertrochanteric fracture (AO/OTA type A1 or A2)
• HA-coated pins in both groups– Group A: oral dose of 70 mg of Alendronate per week
– Group B: no alendronate
• Screw insertion/extraction torque measured at insertion/removal
44
All the devices used in this study are FDA approvedSlides provided by A. Moroni, Bologna, Italy
External fixation device
Pre-op Post-op XX months?
45
• Age (years)
• BMD
• Quality of reduction*
Good
Acceptable
Poor
82 ± 8
543 ± 87
4
3
1
78 ± 6 yrs
527 ± 23
5
2
1
Alendronate(n=8)
Control(n=8)
* Baumgaertner et al. J Bone Joint Surg Am. 1995; 77:1058-64
Baseline characteristics
46
0
1000
2000
3000
4000
5000
P<0.001
Cancellous bone (femoral head)
Screw extraction torque higher for cancellous bone in ALN vs control at 3 months
0
1000
2000
3000
4000
5000Cortical bone (femoral shaft)
ns
Moroni et al. J Bone Joint Surg Am. 2005; 87 Suppl 2:42-51
47
Keep the patient alive
Fix the fracture
Keep patient mobile
Keep patient from returningto your fracture unit
Quality control of process
Acute medical management
Surgical challenges
Multidisciplinary rehab
Osteoporosis managementand secondary prevention
Optimal care of fragility fracture patient:Goals, challenges and solutions
48
Multidisciplinary rehabilitation• Goals
– Restore quality of life through mobility
– Prevent future fractures by preventing falls
• Should be led by the appropriate rehabilitationists
• Discharge planning – integration of medical and social services – needs to start immediately
• Nutrition a vital element – High protein diet improves recovery *
– Vit D insufficiency very common, readily treated
* Duncan et al. Age & Ageing 2006; 35:148-53
49
Secondary prevention• One of the strongest predictors of fragility fracture is
having had one already– Bone strength
– Tendency to fall
• Our response to a fragility fracture must include a determined attempt to prevent another one
• Need not require orthopaedic surgeons to treat,or even remember to refer– Needs a system that achieves this automatically
50
Systems for secondary prevention
• Most reliable when based on nurse specialists, e.g.– Fracture liaison nurses in fracture clinic
– Fragility fracture nurse coordinators for inpatients
• Many different models possible– Key is that responsibility is clear
• Needs local agreement on referral mechanisms between fracture service, osteoporosis service and falls service
• Vital to involve GPs because prevention has to be life-long
• Essential to empower the patient by thorough education
51
Hip Fracture Audit
• Experience (e.g. in Scotland) has shown that ongoing, real-time audit, in conjunction with evidence-based guidelines, can change practice in a non-threatening way
• Preferably national or regional, so that performance can be fed back in context of peers
• Records process and outcome to one year
• Owned and controlled by the professions
• Raises the profile of osteoporosis and fragility fracture work with the managers and commissioners
52
Summary
• Fragility fractures present a serious challenge to fracture services, both because of the high volume and because of their medical, surgical and logistic complexity
• Multidisciplinary working is the key to success and alliance between orthopaedics and geriatrics is particularly valuable
• Surgical technique must be adapted to take account of complications of fracture repair and healing in the elderly
• It is absolutely necessary to deliver secondary prevention reliably to every patient